These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2466127)

  • 41. Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas.
    Greiner JW; Smalley RV; Borden EC; Martin EW; Guadagni F; Roselli M; Schlom J
    J Surg Oncol Suppl; 1991; 2():9-13. PubMed ID: 1909869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway.
    Massa C; Wang Y; Marr N; Seliger B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of antigen expression in human tumor cell populations.
    Greiner JW
    Cancer Invest; 1986; 4(3):239-56. PubMed ID: 2424575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives.
    Hokland M; Basse P; Justesen J; Hokland P
    Cancer Metastasis Rev; 1988 Nov; 7(3):193-207. PubMed ID: 2465842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon treatment of human malignancies--a short review.
    Einhorn S; Strander H
    Med Oncol Tumor Pharmacother; 1993; 10(1-2):25-9. PubMed ID: 7505041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application.
    Roselli F; Chandrasekar A; Morganti-Kossmann MC
    Front Neurol; 2018; 9():458. PubMed ID: 29971040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What roles have anti-interferon antibodies in physiology and pathology?
    Bocci V
    Ric Clin Lab; 1991; 21(1):79-84. PubMed ID: 1714098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon--a candidate mediator of cell growth.
    Tedeschi B
    Adv Exp Med Biol; 1992; 321():53-6; discussion 57-8. PubMed ID: 1280401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells.
    Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW
    J Natl Cancer Inst; 1989 Apr; 81(7):502-12. PubMed ID: 2466127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.
    Greiner JW; Guadagni F; Hand PH; Pestka S; Noguchi P; Fisher PB; Schlom J
    Cancer Treat Res; 1990; 51():413-32. PubMed ID: 1977458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: a review.
    Guadagni F; Roselli M; Schlom J; Greiner JW
    Int J Biol Markers; 1994; 9(1):53-60. PubMed ID: 7519653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: radioimmunoguided surgery and antigen augmentation.
    Roselli M; Buonomo O; Piazza A; Guadagni F; Vecchione A; Brunetti E; Cipriani C; Amadei G; Nieroda C; Greiner JW; Casciani CU
    Semin Surg Oncol; 1998 Dec; 15(4):254-62. PubMed ID: 9829383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.